Responsiveness of blood and sputum inflammatory cells in Japanese COPD patients, non-COPD smoking controls, and non-COPD nonsmoking controls

International Journal of COPD

Volumn 11, Issue , 2016, Pages 295-303

  Kawayama, Tomotaka ^a   Kinoshita, Takashi ^a   Matsunaga, Kazuko ^b   Kobayashi, Akihiro ^c   Hayamizu, Tomoyuki ^c   Johnson, Malcolm ^d   Hoshino, Tomoaki ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b FUKUOKA SANNO HOSPITAL   (Japan)

^c Development and Medical Affairs Division   (Japan)

^d GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Chronic obstructive pulmonary disease; Lipopolysaccharide; Peripheral blood mononuclear cells; Sputum; Tumor necrosis factor

Indexed keywords

GELATINASE B; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; TUMOR NECROSIS FACTOR;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE RELEASE; EOSINOPHIL COUNT; EX VIVO STUDY; FEMALE; HUMAN; HUMAN CELL; JAPANESE (PEOPLE); LYMPHOCYTE COUNT; MACROPHAGE; MALE; NEUTROPHIL; NEUTROPHIL COUNT; PERIPHERAL BLOOD MONONUCLEAR CELL; SMOKING; BLOOD; CELL CULTURE; COMPARATIVE STUDY; CYTOLOGY; INFLAMMATION; LEUKOCYTE COUNT; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; PATHOLOGY; PATHOPHYSIOLOGY; SPUTUM; STATISTICS;

AGED; BIOMARKERS; CELLS, CULTURED; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-6; INTERLEUKIN-8; LEUKOCYTE COUNT; LEUKOCYTES, MONONUCLEAR; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEUTROPHILS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING; SPUTUM; STATISTICS AS TOPIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84957875895     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S95686     Document Type: Article

References (35)

1. Japanese Respiratory Society COPD Guideline ver Tokyo Incorporated Association, JRS; 2013
2. Global Strategy for Diagnosis, Management, and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD); 2014. Available from: http://www.goldcopd.org/
3. Agusti A. Systemic effects of chronic obstructive pulmonary disease: what we know and what we don’t know (but should). Proc Am Torac Soc. 2007;4(7):522–525
4. Agusti AGN. COPD, a multicomponent disease: implications for management. Respir Med. 2005;99(6):670–682
5. Tanni SE, Pelegrino NRG, Angeleli AYO, Correa C, Godoy I. Smoking status and tumor necrosis factor-alpha mediated systemic inflammation in COPD patients. J Inflamm (Lond). 2010;7:29
6. Sarir HI, Mortaz E, Karimi K, et al. Combination of fluticasone propionate and salmeterol potentiates the suppression of cigarette smoke-induced IL-8 production by macrophages. Eur J Pharmacol. 2007;571(1):55–61
7. Ishikawa N, Hattori N, Kohno N, Kobayashi A, Haymizu T, Johnson M. Airway inflammation in Japanese COPD patients compared with smoking and non-smoking controls. Int J Chron Obstruct Pulmon Dis. 2015;10(1):185–192
8. Barnes NC, Qiu YS, Pavord ID, et al. Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease. Am J Respir Crit Care Med. 2006;173(7):736–743
9. Lomas DA, Silverman EK, Edwards LD, Miller BE, Coxson HO, Tal-Singer R. Evaluation of serum CC-16 as a biomarker for COPD in the ECLIPSE cohort. Thorax. 2008;63(12):1058–1063
10. Barnes PJ. Mediators of chronic obstructive pulmonary disease. Pharmacol Rev. 2004;56(4):51–58
11. Dickens JA, Miller BE, Edwards LD, Silverman EK, Lomas DA, Tal-Singer R. COPD association and repeatability of blood biomarkers in the ECLIPSE cohort. Respir Res. 2011;12:146
12. Hasday JD, Bascom R, Costa JJ, Fitzgerald T, Dubin W. Bacterial endotoxin is an active component of cigarette smoke. Chest. 1999;115: 829–835
13. Ngkelo A, Meja K, Yeadon M, Adcock I, Kirkham PA. LPS induced inflammatory responses in human peripheral blood mononuclear cells is mediated through NOX4 and Giα dependent PI-3kinase signaling. J Inflamm (Lond). 2012;9(1):1
14. Sweet MJ, Hume DA. Endotoxin signal transduction in macrophages. J Leukoc Biol. 1996;60(1):8–26
15. Mukhopadhyay S, Hoidal JR, Mukherjee TK. Role of TNF alpha in pulmonary pathophysiology. Respir Res. 2006;7:125
16. MacNee W. Systemic inflammatory biomarkers and co-morbidities of chronic obstructive pulmonary disease. Ann Med. 2013;45(3):291–300
17. Hacievliyagil SS, Mutlu LC, Temel I. Airway inflammatory markers in chronic obstructive pulmonary disease patients and healthy smokers. Niger J Clin Pract. 2013;16(1):76–81
18. Korsgren M, Linden M, Entwistle N, et al. Inhalation of LPS induces inflammatory airway responses mimicking characteristics of chronic obstructive pulmonary disease. Clin Physiol Funct Imaging. 2012;32(1):71–79
19. Leaker BR, Barnes PJ, O’Connor B. Inhibition of LPS-induced airway neutrophilic inflammation in healthy volunteers with an oral CXCR2 antagonist. Respir Res. 2013;14:137
20. Miller MR, Hankinson J, Brusasco F, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319–338
21. Paggiaro PL, Chanez P, Holz O, et al. Sputum induction. Eur Respir J Suppl. 2002;37:3s–8s
22. Asai K, Kobayashi A, Makihara Y, Johnson M. Anti-inflammatory effects of salmeterol/fluticasone propionate 50/250 mcg combination therapy in Japanese patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2015;10(1):803–811
23. Pizzichini E, Pizzichini MM, Efthimiadis A, et al. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med. 1996;154 (2 pt 1):308–317
24. Ayer JG, Song C, Steinbeck K, Celermajer DS, Freedman SB. Increased tissue factor activity in monocytes from obese young adults. Clin Exp Pharmacol Physiol. 2010;37(11):1049–1054
25. Jansky L, Reymanov P, Kopecky J. Dynamics of cytokine production in human peripheral blood mononuclear cells stimulated by LPS or Infected by Borrelia. Physiol Res. 2003;52:593–598
26. Faner R, Tal-Singer R, Riley JH, et al. Lessons from ECLIPSE: a review of COPD biomarkers. Thorax. 2014;69(7):666–672
27. Oudjik EJ, Gerritsen WBM, Nijhuis EHJ, et al. Expression of primingassociated cellular markers on neutrophils during an exacerbation of COPD. Respir Med. 2006;100(10):1791–1799
28. Koethe SM, Kuhnmuench JR, Becker CG. Neutrophil priming by cigarette smoke condensate and a tobacco anti-idiotypic antibody. Am J Pathol. 2000;157(5):1735–1743
29. Aida Y, Pabst MJ. Neutrophil responses to lipopolysaccharide. Effect of adherence on triggering and priming of the respiratory burst. J Immunol. 1991;146(4):1271–1276
30. Stănescu D, Sanna A, Veriter C, et al. Airways obstruction, chronic expectoration, and rapid decline of FEV1 in smokers are associated with increased levels of sputum neutrophils. Thorax. 1996;51(3):267–271
31. Malerba M, Ricciardolo F, Radaeli A, et al. Neutrophilic inflammation and IL-8 levels in induced sputum of alpha-1-antitrypsin PiMZ subjects. Thorax. 2006;61(2):129–133
32. Bazzoni F, Cassatella MA, Rossi F, Ceska M, Dewald B, Baggiolini M. Pagocytosing neutrophils produce and release high amounts of the neutrophil-activating peptide 1/interleukin 8. J Exp Med. 1991;173: 771–774
33. Ravi AK, Khurana S, Lemon J, et al. Increased levels of soluble interleukin-6 receptor and CCL3 in COPD sputum. Respir Res. 2014; 15:103
34. Takabatake N, Nakamura H, Abe S, et al. The relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;161(4 Pt 1):1179–1184
35. Oudijk EJ, Nijhuis EH, Zwank MD, et al. Systemic inflammation in COPD visualised by gene profiling in peripheral blood neutrophils. Thorax. 2005;60:538–544.